Categories Uncategorized

New Study Suggests That Where You Live May Influence Reproductive Health

A recent study conducted by University of Nottingham researchers suggests that the environment in which men inhabit could impact their reproductive health. The study, which was reported in “Scientific Reports,” examined the impact of geographical location on chemicals discovered in testes of dogs. Some of these chemicals have been found to influence reproductive health.

The study centered on dogs because they are common pets and are usually exposed to the same chemicals used in the house as their owners because they live in the same environment.

The group of researchers also searched for any signs of abnormalities in the dogs’ testes, with their findings demonstrating that the extent of abnormalities and the chemicals found present in the testes were different, and mainly depended on where the dog lived in.

The researchers examined the testes of dogs in a bid to determine the chemicals present in the tissue. The samples used in the study had been removed for standard clinical reasons. The samples were obtained from across the United Kingdom, Finland, Denmark and other areas.

Dr. Rebecca Summer, the lead author of the study from the School of Veterinary Medicine and Science stated that the researchers had demonstrated that the profile of pollutants discovered in dog testes was dependent upon where the dog lived. Summer added that the researchers had also found that similar groups of dog testes showed evidence of a cell imbalance as well as regional differences in testicular pathology. The cells are essential for the production of sperms.

Lead for the team of researchers, Dr. Richard Lea, stated that while their research proposed that in comparison to other locations, there were fewer pathologies in dog testes obtained from Finland, and linking this to the chemicals detected was challenging, especially as other pollutants could also be present. Lea added that the group believed that this research was of crucial importance as the approach, which made use of the dog as a sentinel species, had allowed group members to concentrate on testes where the chemicals detected may affect male reproductive health.

Dean of the School of Veterinary Medicine and Science at the University of Nottingham Gary England noted that the research was significant as its findings show that environmental exposures were determined by region, which may support geographical differences in male reproductive health. Other researchers involved in the study include Lena Lindh, Jorgen S. Agerholm, Zulin Zhang and Andrew Byers.

Such a study could potentially result in interventions designed to address the reproductive challenges faced within a given geographical area by relying on IoT platforms, such as the proprietary one owned by RYAH Group Inc., which is helpful to teams conducting clinical trials and those seeking to validate treatment protocols.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…

20 hours ago

Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium

The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…

21 hours ago

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face…

4 days ago

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…

5 days ago

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…

7 days ago

Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…

7 days ago